IP Library Granted Patent US 8,080,641
Granted Patent B2
US 8,080,641 · App. 12/409,361 · Granted Dec 20, 2011

Process for the production of multiple cross-linked hyaluronic acid derivatives

Assignee: Mentor Worldwide LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,080,641
App. No.
12/409,361
Granted
Dec 20, 2011
Kind
B2
Abstract

The present invention relates to a process for the production of cross-linked hyaluronic acid (HA) derivatives, in particular multiple, e.g. double cross-linked hyaluronic acid derivatives. The invention also provides novel cross-linked HA derivatives, products containing them and their uses in medical and pharmaceutical and cosmetic applications.

Claims (19)

1. A process for the preparation of multiple cross-linked hyaluronic acid (HA), which process comprises cross-linking HA via two or more different functional groups, wherein the cross-linking is effected by contacting HA with a first chemical cross-linking agent so as to form a first type of functional bond and sequentially contacting a second chemical cross-linking agent so as to form a second type of functional bond between HA molecules, and wherein at least one of the first or second type of functional bond is an ester bond.

2. A process according to claim 1 wherein the functional groups are selected from hydroxyl, carboxyl and amino.

3. A process according to claim 1 or claim 2 wherein the crosslinking is effected by means of two or more different bonds selected from ether, ester, sulfone, amine, imino and amide bonds.

4. A process according to claim 1 wherein the cross-linking agent is selected from formaldehyde, glutaraldehyde, divinyl sulfone, a polyanhydride, a polyaldehyde, a polyhydric alcohol, carbodiimide, epichlorohydrin, ethylene glycol diglycidylether, butanediol diglycidylether, polyglycerol polyglycidylether, polyethylene glycol diglycidylether, polypropylene glycol diglycidylether, or a bis- or poly epoxy cross-linker.

5. A process according to claim 1 wherein an ether bond is formed using a crosslinking agent selected from bis and poly epoxides under alkaline conditions.

6. A process according to claim 1 wherein an ester bond is formed using a crosslinking agent selected from bis and poly epoxides under acidic conditions.

7. A process according to claim 5 or claim 6 wherein the crosslinker is selected from 1,2,3,4-diepoxybutane and 1,2,7,8-diepoxyoctane.

8. A process according to claim 1 wherein an ether bond is formed using a glutaraldehyde cross-linking agent under acidic conditions.

9. A process according to claim 1 wherein the crosslinking of each type of functional group is effected sequentially.

10. A process according to claim 9 which comprises cross-linking HA via a first functional group and subsequently further cross-linking the product via a second functional group, wherein said first and second functional groups represent different chemical entities.

11. A process according to claim 9 or claim 10 wherein HA is first cross linked via the hydroxyl groups by formation of ether bonds and subsequently cross-linked via the carboxyl groups by formation of ester bonds.

12. A process according to claim 1 for preparing double crosslinked HA.

13. A process according to claim 12 which comprises: (a) cross-linking HA via a first functional group and (b) subsequently further cross-linking the product of (a) via a second functional group, wherein said first and second functional groups represent different chemical entities.

14. Multiple cross-linked HA obtainable by a process according to claim 1 .

15. Cross-linked HA according to claim 14 wherein the crosslinking bonds are selected from two or more of ether, ester, sulfone, amine, imino and amide bonds.

16. Multiple cross-linked HA according to claim 14 in the form of a film.

17. Multiple cross-linked HA according to claim 1 in the form of a gel.

18. HA according to claim 14 which is double cross linked HA.

19. A product comprising multiple cross-linked HA according to claim 14 .

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2020
From: ETHICON, INC.
To: MENTOR WORLDWIDE LLC
Reel/Frame 052226/0248 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2012
From: MENTOR BIOPOLYMERS LIMITED
To: MENTOR CORPORATION
Reel/Frame 027691/0585 →
CHANGE OF NAME Recorded Mar 4, 2010
From: MENTOR CORPORATION
To: MENTOR WORLDWIDE LLC
Reel/Frame 024023/0607 →
Priority Claims (1)
GB 9902412.7 · Feb 3, 1999 · national
Continuity (4)
Continuation 11185575 · Jul 19, 2005
Continuation 09920286 · Aug 2, 2001
Continuation PCTGB0000321 · Feb 3, 2000
Related Publication 20090247741A1 · Oct 1, 2009